Paul Gillard | Vice President, Medical Science & Strategy
PPD clinical research business of ThermoFisher Scientific

Dr. Gillard is a Medical Doctor with a training in internal medicine and has more than 18 years of experience in the clinical development and registration of prophylactic vaccines at GlaxoSmithKline. He has contributed to the development of the human rotavirus vaccine, pandemic influenza vaccine, tuberculosis vaccine, live attenuated viral vaccines and mRNA vaccines.
Dr. Gillard possesses extensive experience leading vaccine candidates through all development stages (Phase I-IV) across a variety of regions, indications, and target populations. He has expertise leading programs with external collaborators in cross-cultural environments. Dr. Gillard received his medical and internal medicine degrees from the University of Brussels, and holds an active internal medicine physician license in Belgium.